Vycor Medical (VYCO) Cash from Financing Activities (2010 - 2026)
Vycor Medical (VYCO) posted quarterly Cash from Financing Activities of -$14910.0 for Q1 2026, up 15.72% year-over-year from -$12885.1 in Q1 2025, and little changed quarter-over-quarter from -$14874.0 in Q4 2025.
Vycor Medical (VYCO) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Cash from Financing Activities for 17 consecutive years, with -$14910.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 15.72% year-over-year to -$14910.0; the TTM figure through Mar 2026 stood at $1968.0 (up 121.25% YoY), while the FY2025 annual figure was -$812.0, up 89.25% from the prior year.
- Cash from Financing Activities held at -$14910.0 in Q1 2026 per VYCO's latest filing, from -$14874.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $68409.0 in Q1 2022 and bottomed at -$17690.0 in Q1 2025.
- Historically, Cash from Financing Activities has averaged $8401.4 across 5 years, with a median of -$8819.0 in 2023.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities surged 293.33% — and 2023, when it sank 130.31%.
- Vycor Medical's Cash from Financing Activities stood at $37497.0 in 2022, then sank by 130.31% to -$11367.0 in 2023, then decreased by 22.06% to -$13874.0 in 2024, then slipped by 7.21% to -$14874.0 in 2025, then slipped by 0.24% to -$14910.0 in 2026.
- Business Quant data shows VYCO's Cash from Financing Activities at -$14910.0 in Q1 2026, -$14874.0 in Q4 2025, and $36957.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -10,246.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14,910.00 |
| Mar 31, 2026 | -14,910.00 |
| Dec 31, 2025 | -14,874.00 |
| Dec 31, 2025 | -14,874.00 |
| Sep 30, 2025 | 36,957.00 |
| Sep 30, 2025 | 36,957.00 |
| Jun 30, 2025 | -5,205.00 |
| Jun 30, 2025 | -5,205.00 |
| Mar 31, 2025 | -17,690.00 |
| Mar 31, 2025 | -17,690.00 |
| Dec 31, 2024 | -13,874.00 |
| Dec 31, 2024 | -13,874.00 |
| Sep 30, 2024 | 32,898.00 |
| Sep 30, 2024 | 32,898.00 |
| Jun 30, 2024 | -10,595.00 |
| Jun 30, 2024 | -10,595.00 |
| Mar 31, 2024 | -15,983.00 |
| Mar 31, 2024 | -15,983.00 |
| Dec 31, 2023 | -11,367.00 |
| Dec 31, 2023 | -11,367.00 |